Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept or Methotrexate in Juvenile Dermatomyositis
NCT00035958Phase 3Terminated
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Aug 2002
- Primary completion
- Aug 2002
- Modality
- Orthosteric Ligands, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of etanercept, methotrexate in juvenile dermatomyositis (JDM), sponsored by Cincinnati Children's Hospital Medical Center. Started Aug 2002; status: terminated.
02
Drugs
etanerceptmethotrexate
03
Conditions
juvenile dermatomyositis (JDM)
Beyond the preview
Go deeper on NCT00035958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00035958.